top of page

A drug discovery platform company focused on structural biology, medicinal chemistry and cell biology.

A drug discovery technology and services company. Completed $54 million IPO in 2000 and acquired by DeCODE genetics inc.


A joint venture between MediChem and the Malaysian government developing HIV drugs.  Acquired by Malaysian government in 2006.


A drug development company focused on infection, cancer and respiratory diseases. Completed $35 million IPO in 2005.


Current Portfolio:

Past Investments:

bottom of page